Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yakutskenergo reported for 6 months of 2023 by RAS

7/27/23 YKEN

Mandatory RuStore pre-installation on smart TVs is canceled

7/27/23 VKCO

TotalEnergies reported for 6 months of 2023

7/27/23 TTE

eBay has reported for 6 months of 2023

7/27/23 EBAY

MaxLinear will not buy Silicon Motion

7/27/23 SIMO

MaxLinear will not buy Silicon Motion

7/27/23 MXL

The eBay announced a quarterly dividend

7/26/23 EBAY

Irkut denies postponement of new Superjet deliveries

7/26/23 IRKT

Globaltrans profit in first half increased 17-fold

7/26/23 GLTR

Globaltrans intends to redomicile from Cyprus to Abu Dhabi

7/26/23 GLTR